{
    "Trade/Device Name(s)": [
        "Diazyme Myoglobin Assay",
        "Diazyme Myoglobin Calibrator Set",
        "Diazyme Myoglobin Control Set"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K123785",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061683",
        "K973358"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DDR",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "June 7, 2013",
    "Summary Letter Received Date": "April 30, 2013",
    "Submission Date": "April 26, 2013",
    "Regulation Number(s)": [
        "21CFR866.5680"
    ],
    "Regulation Name(s)": [
        "Myoglobin immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Myoglobin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Latex enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetric analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Myoglobin Assay, Calibrator Set, and Control Set for quantitative myoglobin measurement in serum and plasma using latex enhanced immunoturbidimetric technology.",
    "Indications for Use Summary": "For quantitative determination of myoglobin in human serum and plasma as an aid in diagnosis of acute myocardial infarction; calibrator and control sets for assay calibration and quality control, for in vitro diagnostic use only.",
    "fda_folder": "Immunology"
}